_id

69104f93ccc777a4e85d53a6

Ticker

CLDX

Name

Celldex Therapeutics Inc

Exchange

NASDAQ

Address

Perryville III Building, Hampton, NJ, United States, 08827

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.celldex.com

Description

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.

Last Close

27.94

Volume

292050

Current Price

27.51

Change

-1.5390121689334277

Last Updated

2025-11-29T11:32:06.758Z

Image

data:image/webp;base64,UklGRo4IAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSPoFAAAN8K5t25tk27at255QgvTeOdCz/D3HfzDO86p26SURRBSMyb7+kOxEhyAiJqAkygJhKPw4+IhbJdMpIQyFYWjDtgRnMviIK2ErwZlh+LvVbatAhARESBG839/tGIv9a1hMC6MIG+tV2+700qIQpSD++OF5H4dV7A+yttJRoPJn82tx8s0aAhGAFNFIOoXE+IkxdDq2vw+0irLE30yXf+ND2h0oE1VoV9zJ9jyn33oPQBqA3vr1iMPjvNytKpiqWvVCj5fnZJql5AYQmO5uZz0AT2O7WKkoHSXMVuoXs9tzOnXrCAqjhK/e5CUJAN7kuT1MCniKIk6nfnyefBoVB7UFAUoUgunCSeNreD8pdooJFQFQ1RupYDkzyVeqjk8YCsPdbNPAaW/9EvT6MBXkB43l4y7KvupuDzCX9fRgORF6Pd02BxcQniJEDbvvK29/Ssr92pwgxIAPMxum44Vkm2VEAFSZUiM3vueJbgf7EKYCLsebvNF+ttPNroIB5GLYXI22X5xBY0cQEgWuV3uceXiYF1r1FPQpAKped8LRCsg087YLUwG2N/M+AKEBRmOVr1UVojXSzXpmdgt06vIeUgzA183kJQmAMOXzyOteJgU8BUD9avkvo2S/tfJByikhDvN1Jo3zw/tJsVOylQFZbzt8Oxazn4Tx8XXx0kCcO8/76A1gSJF8q1m0pkeYizt/U04s2IzdxiAL4SkAqt2v2muCEAOOFgpxT+afTrcBA6pcLqF9wlCAxWSTj+11/ux3fykYIJmCDgNYUeBqvcc3HsarbK2RhD4FiAAgeEqA7f+nvwAIY8JiHjrVmkI0CSjFCHD/PNoqAETc3IzczjAt4ClzIY6zddbG9wb300K7lFRGBCD4etwtdi18985zj/1fiFfmIz+V+TZsRuvGMAthDLybJPETx/PA6dVxBkXA5WKf/hHH0bPfGSqcSQlc18dPvZlmaq200ibCz5fr2eWPWS/sfD4HY+Hn26Ob/DGSSNlHbQaxE4ofwU+pFniEpphQEheVrDv9IZlBY3UEzACkf+8uHzY/IlVqF1caZxKSuOztl97uJ3Ta+jWkmUCDFir9ytMtv8/p1180NJUJAAKifus/j11+V7adly3OFyEhhUq/cPPv7+o1+QYtchZAMFn4o/3wn8P3lHrVpQZoIAABAkKxUtmM+KvP78hXKqlPjRhJEUCUnS7nvOk3WJfd7RGkRKkThIBaBCLZP/uT601sUu5XphqEgUaoLRsQ0YQQkrq8epm4r3H1e3r3CVOF1SJIVqsWAQEIAZAf1p5uGY8zbL1oaKgo6PHUTzWaaRGIkCCh+NtwM3IZR66dU1uYKoTe2j1IrV1yQAAIQisBKVQGhet/x9FtYg8tEgW98d59n+lctawICEJtWWCy8Hv78T+H80rt0loDjBDCf5wWM3h7XHSuLgQkbEUGYdLJZJKYH84plIuJNw1Dob+dbmsAbh4K3ZKjCNgWGFAlVLJRdMdn2Jed3Q6kREGNH62iAuC7y9fuUASgEJalaV0M6qvRxkhKvdpCgzDRN9MiTh4e5vVBHkIQYlukSneb7663M6l3rEMAU4X9w7u6OIXFyk90avgqAAHLLnZK03vf4Kq119BQUdCPs4SDyPe1d2gOFQVCUAhI6qrjjTfBqXS/nHRhqqC9sdeG4WG0yNabKZACQCiQWi3D2exUr2UfoEWioDfuSwjj+TR06nVFoQAQaiTqzdxydPhS6lZWBBghgH89aabNsL1ftH+/EJCCrwIZtMLtbA8UyuXUmxZEiw42I6/iiDbizVOhXXYUQUAgBMudDBdjWFf93RsAFQV5GqeKYgvMfXf52h2KQrQgN2huFqlUr77Q0IgUqv3TsgaEOPfwOK/18xRGQLHbDfZ/MTy+Hgkl1EqoRXurz2QBcS5WH1azgc9TAko632n8ob3Vdk+llNZKaW3pzc4pSSzva/etUJHgFEBIejAYBaORtsMwhChNWJJwCl0L8R5mo9UOCRIQAQBaufx/w8lMpXWgtVJaK6XsvGMh7uVk6kryFAFopFJWUDggbgIAAPANAJ0BKkAAQAA+oTyXSaYjIiE3+q34wBQJbACyUcD+q9Y1zax4AZyvbLc9vpku8X4DW+gdzdYFvb/Zke2uyys0McHdPFHGRnrFgI1Nkr7uxS5Hl6D/gyOlcJ6fY9ndAE11TxTZrp8qn49E5rAM7+c1ltIX13dcAAD+6nBJNDg3Nomnu+3MtVzNOEZj8jFdnhYZ0c8Iy+1dHJDu131vncOY8DJf55BpATjKttpYha5bClAKaQxgj/tuIxdyj38CZw+E/M0nY4rdMSp9P4x0Wa2EhTV1Q0tXyaaq4uz4w1LBlO6Fk1PMJgUVHLa7xF6pPjlms1PiwaVx7gAGF0x6rOf+Oc+4c/PHtfJn/nQSBLa5tibMqdLF7kwVSNb8Q3UEjz6NNlL0z+rTdRfPahFSra9k4g0RzO4mbNdiabZzKutLbB2c+266GVYagxfriwgAtj8gx++580mDvI1MQ2ak1AJ2MNkRTvcu4WDGtTEnZOUgztxS+4Yw/HrKPvv/v8MMVITLpb6UMFns6j+DBZG9IlP5i3ve+oensy54FmIBn1gspYV97AIPZ/vRvPoqsBjlIj9UGrGvGNIBUabVeBC1bO6Sl5UIDyNSiRPfpLKO/3jR7f6z35jwfeHc8kdet4Kpp/OT3m+tl+fDavuEDOdqByh7FjnxM9a29Px5w0SLiDfFuWstBm8wj6IngXfjtuflcVP5jU7IxAT9x/+kyYbPq5i1BqXpmzMzF5iwLvj3cfknK5tX8AIdjRBJ0CcmcR6f/Zv6VfM5HwdOpkAl2WOJm4ISUkAl7Icpl1Hx42GgRU3GwRRU0FeOOHWv5BwKAAA=

Ipo Date

2008-03-10T00:00:00.000Z

Market Cap

1795464704

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7978799999999999

Sentiment Sources

10

Rating

4.5714

Target Price

53.1429

Strong Buy

10

Buy

2

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

62931000

Gross Profit

-62931000

Operating Expenses

73617000

Operating Income

-73617000

Interest Expense

-

Pretax Income

-67044000

Net Income

-67044000

Eps

-1.0093947606142728

Dividends Per Share

-

Shares Outstanding

66449471

Income Tax Expense

-

EBITDA

-66220000

Operating Margin

-

Total Other Income Expense Net

6573000

Cash

36037000

Short Term Investments

547186000

Receivables

90000

Inventories

-

Total Current Assets

604339000

Property Plant Equipment

7546000

Total Assets

648439000

Payables

4267000

Short Term Debt

1553000

Long Term Debt

-

Total Liabilities

50076000

Equity

598363000

Depreciation

824000

Change In Working Capital

9803000

Cash From Operations

-48628000

Capital Expenditures

440000

Cash From Investing

60847000

Cash From Financing

774000

Net Change In Cash

12993000

PE

-

PB

3.0536884800697903

ROE

-11.204569801274477

ROA

-10.339291745252831

FCF

-49068000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

62931000

Quarters > 0 > income Statement > gross Profit

-62931000

Quarters > 0 > income Statement > operating Expenses

73617000

Quarters > 0 > income Statement > operating Income

-73617000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-67044000

Quarters > 0 > income Statement > net Income

-67044000

Quarters > 0 > income Statement > eps

-1.0093947606142728

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

66420000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-66220000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

6573000

Quarters > 0 > balance Sheet > cash

36037000

Quarters > 0 > balance Sheet > short Term Investments

547186000

Quarters > 0 > balance Sheet > receivables

90000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

604339000

Quarters > 0 > balance Sheet > property Plant Equipment

7546000

Quarters > 0 > balance Sheet > total Assets

648439000

Quarters > 0 > balance Sheet > payables

4267000

Quarters > 0 > balance Sheet > short Term Debt

1553000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

50076000

Quarters > 0 > balance Sheet > equity

598363000

Quarters > 0 > cash Flow > net Income

-67044000

Quarters > 0 > cash Flow > depreciation

824000

Quarters > 0 > cash Flow > change In Working Capital

9803000

Quarters > 0 > cash Flow > cash From Operations

-48628000

Quarters > 0 > cash Flow > capital Expenditures

440000

Quarters > 0 > cash Flow > cash From Investing

60847000

Quarters > 0 > cash Flow > cash From Financing

774000

Quarters > 0 > cash Flow > net Change In Cash

12993000

Quarters > 0 > ratios > PE

-1.0093947606142728

Quarters > 0 > ratios > PB

3.0536884800697903

Quarters > 0 > ratios > ROE

-11.204569801274477

Quarters > 0 > ratios > ROA

-10.339291745252831

Quarters > 0 > ratios > FCF

-49068000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

730000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

730000

Quarters > 1 > income Statement > operating Expenses

64587000

Quarters > 1 > income Statement > operating Income

-63857000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-56600000

Quarters > 1 > income Statement > net Income

-56600000

Quarters > 1 > income Statement > eps

-0.8525123508856489

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

66392000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-62984000

Quarters > 1 > income Statement > operating Margin

-8747.534246575342

Quarters > 1 > income Statement > total Other Income Expense Net

7257000

Quarters > 1 > balance Sheet > cash

23044000

Quarters > 1 > balance Sheet > short Term Investments

607293000

Quarters > 1 > balance Sheet > receivables

90000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

648404000

Quarters > 1 > balance Sheet > property Plant Equipment

7513000

Quarters > 1 > balance Sheet > total Assets

692407000

Quarters > 1 > balance Sheet > payables

2073000

Quarters > 1 > balance Sheet > short Term Debt

1536000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

37001000

Quarters > 1 > balance Sheet > equity

655406000

Quarters > 1 > cash Flow > net Income

-56600000

Quarters > 1 > cash Flow > depreciation

873000

Quarters > 1 > cash Flow > change In Working Capital

4217000

Quarters > 1 > cash Flow > cash From Operations

-44005000

Quarters > 1 > cash Flow > capital Expenditures

728000

Quarters > 1 > cash Flow > cash From Investing

49850000

Quarters > 1 > cash Flow > cash From Financing

63000

Quarters > 1 > cash Flow > net Change In Cash

5908000

Quarters > 1 > ratios > PE

-0.8525123508856489

Quarters > 1 > ratios > PB

2.786736648733762

Quarters > 1 > ratios > ROE

-8.635868454057485

Quarters > 1 > ratios > ROA

-8.174382985729492

Quarters > 1 > ratios > FCF

-44733000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-61.278082191780825

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

695000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

695000

Quarters > 2 > income Statement > operating Expenses

63434000

Quarters > 2 > income Statement > operating Income

-62739000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-53796000

Quarters > 2 > income Statement > net Income

-53796000

Quarters > 2 > income Statement > eps

-0.8103882017986532

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

66383000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-61872000

Quarters > 2 > income Statement > operating Margin

-9027.194244604318

Quarters > 2 > income Statement > total Other Income Expense Net

8943000

Quarters > 2 > balance Sheet > cash

17136000

Quarters > 2 > balance Sheet > short Term Investments

656155000

Quarters > 2 > balance Sheet > receivables

1064000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

693757000

Quarters > 2 > balance Sheet > property Plant Equipment

8115000

Quarters > 2 > balance Sheet > total Assets

739471000

Quarters > 2 > balance Sheet > payables

3410000

Quarters > 2 > balance Sheet > short Term Debt

1499000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

36490000

Quarters > 2 > balance Sheet > equity

702981000

Quarters > 2 > cash Flow > net Income

-53796000

Quarters > 2 > cash Flow > depreciation

867000

Quarters > 2 > cash Flow > change In Working Capital

-8496000

Quarters > 2 > cash Flow > cash From Operations

-54372000

Quarters > 2 > cash Flow > capital Expenditures

265000

Quarters > 2 > cash Flow > cash From Investing

42950000

Quarters > 2 > cash Flow > cash From Financing

202000

Quarters > 2 > cash Flow > net Change In Cash

-11220000

Quarters > 2 > ratios > PE

-0.8103882017986532

Quarters > 2 > ratios > PB

2.5977890298599817

Quarters > 2 > ratios > ROE

-7.6525539097073745

Quarters > 2 > ratios > ROA

-7.274930321811132

Quarters > 2 > ratios > FCF

-54637000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-78.61438848920864

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1175000

Quarters > 3 > income Statement > cost Of Revenue

819000

Quarters > 3 > income Statement > gross Profit

356000

Quarters > 3 > income Statement > operating Expenses

56383000

Quarters > 3 > income Statement > operating Income

-56027000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-47092000

Quarters > 3 > income Statement > net Income

-47092000

Quarters > 3 > income Statement > eps

-0.7097192396684285

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

66352999

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-55208000

Quarters > 3 > income Statement > operating Margin

-4768.255319148936

Quarters > 3 > income Statement > total Other Income Expense Net

8935000

Quarters > 3 > balance Sheet > cash

28356000

Quarters > 3 > balance Sheet > short Term Investments

696925000

Quarters > 3 > balance Sheet > receivables

700000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

747159000

Quarters > 3 > balance Sheet > property Plant Equipment

8244000

Quarters > 3 > balance Sheet > total Assets

792340000

Quarters > 3 > balance Sheet > payables

3265000

Quarters > 3 > balance Sheet > short Term Debt

1452000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

45335000

Quarters > 3 > balance Sheet > equity

747005000

Quarters > 3 > cash Flow > net Income

-47092000

Quarters > 3 > cash Flow > depreciation

819000

Quarters > 3 > cash Flow > change In Working Capital

7376000

Quarters > 3 > cash Flow > cash From Operations

-32476000

Quarters > 3 > cash Flow > capital Expenditures

756000

Quarters > 3 > cash Flow > cash From Investing

24047000

Quarters > 3 > cash Flow > cash From Financing

386000

Quarters > 3 > cash Flow > net Change In Cash

-8043000

Quarters > 3 > ratios > PE

-0.7097192396684285

Quarters > 3 > ratios > PB

2.443586056974184

Quarters > 3 > ratios > ROE

-6.304107736896005

Quarters > 3 > ratios > ROA

-5.943408132872252

Quarters > 3 > ratios > FCF

-33232000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-28.282553191489363

Quarters > 3 > health Score

35

Valuation > metrics > PE

-1.0093947606142728

Valuation > metrics > PB

3.0536884800697903

Valuation > final Score

49.463115199302095

Valuation > verdict

1.8% Overvalued

Profitability > metrics > ROE

-11.204569801274477

Profitability > metrics > ROA

-11.093773527771665

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.08368832965942079

Risk > metrics > Interest Coverage

-89.34101941747574

Risk > final Score

-297

Risk > verdict

High

Liquidity > metrics > Current Ratio

103.83831615120275

Liquidity > metrics > Quick Ratio

103.83831615120275

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

20

Prev Risks > 1

29

Prev Risks > 2

32

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:20:29.553Z